ENDRA Life Sciences Inc. (NDRA) › Shareholders' EquityENDRA Life Sciences Inc. (NDRA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2016: -$893.8K2017: $5.28M2018: $6.25M2019: $4.76M2020: $7.17M2021: $10.78M2022: $7.20M2023: $5.66M2024: $2.56M2025: $2.26M$2.26M2016Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$2.26M-11.7%2024$2.56M-54.8%2023$5.66M-21.5%2022$7.20M-33.2%2021$10.78M+50.4%2020$7.17M+50.6%2019$4.76M-23.8%2018$6.25M+18.4%2017$5.28M+690.3%2016-$893.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share